Nuestros investigadores

Francisco Javier Cervera Paz

Publicaciones científicas más recientes (desde 2010)

Autores: Pascual, Marién; Alignani, D.; et al.
Revista: CLINICAL OTOLARYNGOLOGY
ISSN 1749-4478  Vol. 41  Nº 5  2016  págs. 606-611
Autores: Manrique, Raquel; Picciafuoco, S.; Cervera, Francisco Javier; et al.
Revista: EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
ISSN 0937-4477  Vol. 270   Nº 1  2013  págs. 45 - 52
The purpose of this study is to determine if surgical approach to the inner ear is feasible without generating a hearing loss in an animal model. Five Macaca fascicularis were used as experimental animals and followed up for 27 months. Mastoidectomy, posterior tympanotomy and promontorial cochleostomy were performed on four specimens and one specimen was kept as control animal. Before and after drilling and exposing the endosteal layer and the membranous labyrinth, otoacustic emissions (dPOAE) and auditory brainstem responses (ABR) were used to test hearing. In vivo experimental studies prove it is reliable to expose the membranous labyrinth without causing hearing loss. dPOAE were present after 3, 6, 12, 24 and 26 months of follow-up. Regarding the ABR results from the four M. fascicularis in which a cochleostomy has been carried out, auditory thresholds are within the 20-30 dB interval at 27 months of follow-up. Experimental studies support clinical experiences indicating it is feasible to surgically approach the membranous labyrinth of the cochlea without damaging its hearing function.
Autores: Cervera, Francisco Javier; Manrique, Manuel Jesús;
Revista: FIAPAS
ISSN 1135-3511  Vol. 141  2012  págs. 1 - 7
Autores: Cervera, Francisco Javier; Salvador, Francisco Javier; et al.
Revista: REVUE DE LARYNGOLOGIE - OTOLOGIE - RHINOLOGIE
ISSN 0035-1334  Vol. 132  Nº 3  2011  págs. 153-155.
The treatment of patients with idiopathic sudden sensorineural hearing loss must be performed as an emergency measure in order to prevent long term hearing deficit. Steroids in monotherapy provide the best outcome. There is some controversy regarding the most efficient route but in order to prevent side effects, intratympanic treatment is the preferred choice, especially in diabetic patients. We here present the case of a patient that developed hyperglycemia after systemic and intratympanic dexamethasone treatment for sudden hearing loss. We conclude that after intratympanic treatment great caution must be taken.
Autores: Cervera, Francisco Javier;
Revista: REVISTA DE NEUROLOGIA
ISSN 0210-0010  Vol. 50  Nº 2  2010  págs. 65 - 71
The findings of our study both agree and disagree with some earlier works from the literature, which suggests that patients with AD may have their own auditory pattern.
Autores: Pérez-Fernandez, Nicolás; Cervera, Francisco Javier; et al.
Revista: AUDIOL NEURO-OTOL
ISSN 1420-3030  Vol. 15  Nº 6  2010  págs. 399 - 406

ACTIVIDAD DOCENTE